News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,950 Results
Type
Article (40023)
Company Profile (250)
Press Release (664676)
Multimedia
Podcasts (60)
Webinars (14)
Section
Business (204282)
Career Advice (2011)
Deals (35453)
Drug Delivery (95)
Drug Development (81144)
Employer Resources (172)
FDA (16251)
Job Trends (14887)
News (345511)
Policy (32608)
Tag
Academia (2556)
Accelerated approval (10)
Adcomms (22)
Allergies (95)
Alliances (49569)
ALS (109)
Alzheimer's disease (1445)
Antibody-drug conjugate (ADC) (151)
Approvals (16248)
Artificial intelligence (311)
Autoimmune disease (28)
Automation (19)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (122)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (34)
Breast cancer (366)
Cancer (2873)
Cardiovascular disease (213)
Career advice (1681)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (500)
Cervical cancer (22)
Clinical research (66866)
Collaboration (1016)
Company closure (3)
Compensation (689)
Complete response letters (23)
COVID-19 (2625)
CRISPR (57)
C-suite (329)
Cystic fibrosis (113)
Data (3007)
Decentralized trials (2)
Denatured (20)
Depression (61)
Diabetes (346)
Diagnostics (6424)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (138)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (129)
Earnings (87463)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113749)
Executive appointments (845)
FDA (17909)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (934)
Gene editing (131)
Generative AI (22)
Gene therapy (375)
GLP-1 (783)
Government (4503)
Grass and pollen (4)
Guidances (181)
Healthcare (18839)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (147)
Immuno-oncology (9)
Indications (39)
Infectious disease (2797)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (120)
Interviews (312)
IPO (16591)
IRA (44)
Job creations (3637)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (494)
Leadership (18)
Legal (7929)
Liver cancer (79)
Longevity (11)
Lung cancer (401)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (388)
MASH (90)
Medical device (13465)
Medtech (13470)
Mergers & acquisitions (19583)
Metabolic disorders (849)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (32)
Neuroscience (2124)
NextGen: Class of 2025 (6517)
Non-profit (4488)
Now hiring (47)
Obesity (428)
Opinion (217)
Ovarian cancer (101)
Pain (106)
Pancreatic cancer (121)
Parkinson's disease (186)
Partnered (22)
Patents (299)
Patient recruitment (167)
Peanut (50)
People (57693)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20833)
Phase II (29452)
Phase III (21920)
Pipeline (1639)
Policy (200)
Postmarket research (2563)
Preclinical (8872)
Press Release (64)
Prostate cancer (140)
Psychedelics (37)
Radiopharmaceuticals (253)
Rare diseases (460)
Real estate (5917)
Recruiting (66)
Regulatory (22640)
Reports (50)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (157)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3588)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (38)
Vaccines (780)
Venture capital (54)
Weight loss (257)
Women's health (47)
Worklife (16)
Date
Today (82)
Last 7 days (355)
Last 30 days (1823)
Last 365 days (31182)
2025 (16843)
2024 (35219)
2023 (40077)
2022 (51173)
2021 (55710)
2020 (54084)
2019 (46538)
2018 (35018)
2017 (32110)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (38215)
Australia (6232)
California (7449)
Canada (2361)
China (672)
Colorado (320)
Connecticut (319)
Delaware (192)
Europe (82114)
Florida (1119)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (638)
India (27)
Indiana (361)
Iowa (17)
Japan (229)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1025)
Massachusetts (5535)
Michigan (246)
Minnesota (451)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2080)
New Mexico (28)
New York (2085)
North Carolina (1081)
North Dakota (8)
Northern California (3281)
Ohio (236)
Oklahoma (16)
Oregon (34)
Pennsylvania (1614)
Puerto Rico (17)
Rhode Island (36)
South America (1098)
South Carolina (34)
South Dakota (1)
Southern California (2788)
Tennessee (126)
Texas (1127)
United States (27604)
Utah (220)
Virginia (186)
Washington D.C. (72)
Washington State (634)
West Virginia (4)
Wisconsin (66)
704,950 Results for "vaxart inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by various regulatory roadblocks.
April 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders
May 30, 2025
·
4 min read
Press Releases
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2025
May 21, 2025
·
2 min read
Press Releases
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 16, 2025
·
4 min read
Press Releases
Vaxart Announces Adjournment of Annual Meeting of Stockholders
May 22, 2025
·
6 min read
Press Releases
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
May 29, 2025
·
1 min read
Press Releases
Vaxart Appoints Jeroen Grasman as Chief Financial Officer
May 14, 2025
·
6 min read
Press Releases
Vaxart to Present at the Citizens Life Sciences Conference
May 1, 2025
·
1 min read
Press Releases
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 27, 2025
March 28, 2025
·
2 min read
Press Releases
Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
May 5, 2025
·
8 min read
1 of 70,495
Next
